ATTITUDES OF ADOLESCENT/YOUNG ADULT WOMEN TOWARD HUMAN PAPILLOMAVIRUS VACCINATION AND CLINICAL TRIALS

Authors: Hoover, Donald R.¹; Carfioli, Beth²; Moench, Elizabeth A.²

Source: Health Care For Women International, Volume 21, Number 5, 1 July 2000 , pp. 375-391(17)

Publisher: Routledge, part of the Taylor & Francis Group

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Human papillomavirus (HPV) is the most common sexually transmitted infection. It often inflicts adolescents and young adults shortly after onset of sexual activity. More than 30 types of HPV infect the anogenital area; some HPV types cause cervical cancer in women decades after infection, whereas other types cause genital warts in both men and women within a year after infection. Vaccines are being developed against oncogenic and wart-producing HPV. Knowledge of HPV and attitudes toward HPV vaccination/clinical trial participation among 60 female adolescents and young adults were evaluated. Knowledge of HPV in this group was limited, but almost all participants would be interested in receiving vaccines that prevented cervical cancer and genital warts. Only 30% were likely to participate in an HPV clinical trial that required shots and pelvic examinations. A key motivating factor for clinical trial participation was the potential for a vaccine to help other women.

Document Type: Research article

DOI: 10.1080/07399330050082227

Affiliations: 1: Rutgers University Piscataway, New Jersey, USA 2: The MediciGroup Incorporated Wayne, Pennsylvania, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$29.87 plus tax